首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   153483篇
  免费   31107篇
  国内免费   2438篇
耳鼻咽喉   5204篇
儿科学   5404篇
妇产科学   2439篇
基础医学   3433篇
口腔科学   1535篇
临床医学   26855篇
内科学   47955篇
皮肤病学   7503篇
神经病学   14989篇
特种医学   6469篇
外科学   41380篇
综合类   252篇
现状与发展   72篇
一般理论   5篇
预防医学   7086篇
眼科学   3368篇
药学   1091篇
中国医学   14篇
肿瘤学   11974篇
  2024年   690篇
  2023年   4812篇
  2022年   1255篇
  2021年   3202篇
  2020年   6083篇
  2019年   2245篇
  2018年   7485篇
  2017年   7399篇
  2016年   8499篇
  2015年   8509篇
  2014年   15572篇
  2013年   15763篇
  2012年   5746篇
  2011年   5669篇
  2010年   10457篇
  2009年   14311篇
  2008年   5957篇
  2007年   4135篇
  2006年   6597篇
  2005年   3884篇
  2004年   3121篇
  2003年   2096篇
  2002年   2161篇
  2001年   3797篇
  2000年   3006篇
  1999年   3221篇
  1998年   3661篇
  1997年   3462篇
  1996年   3365篇
  1995年   3213篇
  1994年   1959篇
  1993年   1564篇
  1992年   1380篇
  1991年   1411篇
  1990年   1061篇
  1989年   1184篇
  1988年   1016篇
  1987年   855篇
  1986年   892篇
  1985年   718篇
  1984年   551篇
  1983年   527篇
  1982年   515篇
  1981年   405篇
  1980年   362篇
  1979年   312篇
  1978年   329篇
  1977年   400篇
  1975年   277篇
  1972年   304篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.

Background

Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.

Patients and Methods

We conducted a multicenter retrospective analysis in the Triveneto region of Italy.

Results

One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.

Conclusion

This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined.  相似文献   
36.
Marielle Kabbouche MD  FAHS 《Headache》2015,55(10):1426-1429
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations.  相似文献   
37.
38.
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号